Alliancebernstein L.P. Arcutis Biotherapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 111,160 shares of ARQT stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,160

Previous 111,160 -0.0%

Holding current value

$1.03 Million

Previous $1.03 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $263,970 - $456,843	36,460 Added 48.81%	111,160 $1.03 Million
Q1 2024 May 14, 2024	BUY	$3.25 - $11.77 $24,180 - $87,568	7,440 Added 11.06%	74,700 $740,000
Q4 2023 Feb 14, 2024	SELL	$1.84 - $4.82 $9,384 - $24,582	-5,100 Reduced 7.05%	67,260 $217,000
Q3 2023 Nov 14, 2023	SELL	$5.31 - $10.98 $40,727 - $84,216	-7,670 Reduced 9.58%	72,360 $384,000
Q2 2023 Aug 15, 2023	SELL	$7.51 - $15.0 $514,209 - $1.03 Million	-68,470 Reduced 46.11%	80,030 $762,000
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $1.13 Million - $1.89 Million	110,000 Added 285.71%	148,500 $1.63 Million
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $142,392 - $208,080	10,200 Added 36.04%	38,500 $569,000
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $130,639 - $177,600	8,000 Added 39.41%	28,300 $603,000
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $22,470 - $38,250	1,500 Added 7.98%	20,300 $421,000
Q2 2021 Jul 30, 2021	BUY	$24.42 - $34.75 $124,542 - $177,225	5,100 Added 37.23%	18,800 $513,000
Q1 2021 May 06, 2021	SELL	$24.47 - $36.98 $51,387 - $77,658	-2,100 Reduced 13.29%	13,700 $396,000
Q4 2020 Feb 08, 2021	SELL	$17.82 - $31.73 $1.07 Million - $1.9 Million	-59,864 Reduced 79.12%	15,800 $444,000
Q3 2020 Nov 12, 2020	SELL	$23.44 - $32.28 $39,848 - $54,876	-1,700 Reduced 2.2%	75,664 $2.22 Million
Q2 2020 Aug 13, 2020	BUY	$24.48 - $36.56 $208,765 - $311,783	8,528 Added 12.39%	77,364 $2.34 Million
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $1.27 Million - $2.54 Million	68,836 New	68,836 $2.05 Million

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Arcutis Biotherapeutics, Inc. Transaction History